Biology Is Only Limited by Our Own Imagination Today
Building on advances in genomics, machine learning, engineering, and manufacturing, Alexis Bio’s patented platform unlocks the greatest manufacturer of all: Nature.
Alexis Bio is applying nature’s insights to code biological solutions starting with our body’s largest organ and primary immune barrier – our skin… and that’s just the beginning.
Here’s What our Engineers, Scientists,
and Leaders are Delivering Today
Xeno-Skin® by Alexis Bio is the first live biotherapeutic skin xenotransplant to complete a Phase 1 Clinical Trial and the first to receive U.S. FDA Orphan Drug Designation. Partnering burn centers and industry thought leaders believe that Xeno-Skin® will become an important medical countermeasure for the treatment of
Xeno-Nerve® by Alexis Bio is under peer-review in a major medical journal reporting findings from a large preclinical series evaluating the safety and efficacy of a novel live biotherapeutic nerve xenotransplant. Alexis Bio has prepared an Investigational New Drug (IND) Application ready for submission to the U.S. FDA. Damaged nerves disrupt the brain’s communication with the body, impairing the ability to move, feel, and live pain-free. There is an unmet need for large gap peripheral nerve damage and live xenogeneic nerve transplants offer a new solution to help restore a patient’s quality of life.
Alexis Bio is prepared to submit an Investigational New Drug (IND) Application to the U.S. FDA for developing an alternative cell source for dopaminergic neurons (AB001) lost or damaged inside the brains of patients with Parkinson’s Disease.
"If the misery of our poor be caused not by the laws of nature, but by our institutions, great is our sin."
- Charles Darwin